News room - Egetis Therapeutics

18 August, 2015 Interim report second quarter 2015 News English Report Interim Q2 IR Optional

26 June, 2015 PLEDPHARMA PRESENTS ADDITIONAL RESULTS FROM A PHASE IIB STUDY WITH PLEDOX® AT THE SCIENTIFIC CONFERENCE MASCC News English IR Optional

21 April, 2015 Interim report first quarter 2015 News English Report Interim Q1 IR Optional

29 March, 2015 PLEDPHARMA PRESENTS TOP-LINE RESULTS FROM ITS PHASE IIb STUDY – PLEDOX® REDUCES NERVE DAMAGE IN CONJUNCTION WITH CHEMOTHERAPY BY 43 PERCENT News English IR Optional

17 February, 2015 Year-end report 2014 News English Report Interim Yearend IR Optional

17 December, 2014 PledPharma’s rights issue oversubscribed by 34 percent News English IR Optional

14 November, 2014 More than 50 percent of the owners confirm subscription commitments in PledPharma’s planned rights issue News English IR Optional

24 October, 2014 PledPharma AB - Interim report third quarter 2014 News English Report Interim Q3 IR Optional

24 October, 2014 PledPharma presents a new project against acetaminophen-induced poisoning, aimed to be financed by a rights issue News English IR Optional

21 October, 2014 The PLIANT study is fully recruited and the final futility analysis approved News English IR Optional

12 September, 2014 Information video about PLIANT study available News English IR Optional

10 September, 2014 PledPharma awarded Nordic Star of the Year News English IR Optional

9 September, 2014 The second futility analysis in the PLIANT study completed and approved News English IR Optional

28 August, 2014 PledPharma AB - Interim report second quarter 2014 News English Report Interim Q2 IR Optional

26 August, 2014 Positive data from an additional 5 patients in the first part of the PLIANT study News English IR Optional

18 August, 2014 Futility analysis in PLIANT study completed and approved by the DSMB News English IR Optional

13 May, 2014 Rights issue in PledPharma oversubscribed News English IR Optional

25 April, 2014 PledPharma AB (publ) Interim report first quarter 2014 News English Report Interim Q1 IR Optional

23 April, 2014 Go-ahead for PledPharma to also include Avastin patients in Part 2 of the PLIANT study News English IR Optional

24 March, 2014 PledPharma AB (publ) issues new shares News English IR Optional

19 February, 2014 Year end report 2013 News English Report Interim Yearend IR Optional

18 February, 2014 PledPharma brings forward publication date for full year report 2013 News English IR Optional

12 February, 2014 Positive data from the first part of the PLIANT study News English IR Optional

10 December, 2013 First patient treated in part 2 of the PLIANT-study News English IR Optional

18 November, 2013 Nomination Committee for the 2014 Annual General Meeting in PledPharma AB News English IR Optional

Press releases